HSPDA Treatment – Does the Outcome Reflect Reality?

The article addresses the study by Kainth et al on the use of paracetamol for treating patent ductus arteriosus (PDA) in preterm neonates, noting several observations. Topics include the impact of changes in fluid management protocols on PDA incidence and outcomes, the definition and clinical features of hemodynamically significant PDA (hsPDA), and the need for a comprehensive assessment of paracetamol's potential side effects.